Posted by JohnB on November 11, 1999, at 23:14:56
In reply to Re: Same Study, But , Yes, You are Missing the Point, posted by Rick on November 11, 1999, at 15:29:02
The sample size at 3600 mg/day was "insufficient" for the manufacturer to make claims with regards to efficacy at that specific dosage. Parke-Davis does not want to be "burned" by contradicting results from a broader fixed-dose follow-up controlled study, however unlikely that is to happen. The eventual goal is to obtain FDA approval to market Gabapentin for treament of social phobia. Further, there are some indications that slightly higher dosages, sucha as 4800 mg/day, may be even more effective.
JohnB
poster:JohnB
thread:14991
URL: http://www.dr-bob.org/babble/19991108/msgs/15047.html